[go: up one dir, main page]

MX2019015673A - COMPOSITION OF VETERINARY GRANULES CONTAINING CA? AMO EXTRACT. - Google Patents

COMPOSITION OF VETERINARY GRANULES CONTAINING CA? AMO EXTRACT.

Info

Publication number
MX2019015673A
MX2019015673A MX2019015673A MX2019015673A MX2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A
Authority
MX
Mexico
Prior art keywords
extract
veterinary
amo
composition
granules containing
Prior art date
Application number
MX2019015673A
Other languages
Spanish (es)
Inventor
Halperin Wernli Miriam
Wernli Jorge
Batista Trepp Gian
Huber Silvia
Madea Franco
Original Assignee
Creso Pharma Switzerland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creso Pharma Switzerland Gmbh filed Critical Creso Pharma Switzerland Gmbh
Publication of MX2019015673A publication Critical patent/MX2019015673A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Las composiciones veterinarias o los suplementos dietéticos o alimenticios son útiles en la prevención o el tratamiento de trastornos de comportamiento, que se relacionan respectivamente con la edad, problemas y dolores en mamíferos. También son para apoyar o fortalecer el sistema inmune, el equilibrio conductual de los mamíferos y para apoyar la respuesta inflamatoria natural. Estas composiciones o suplementos están en forma de gránulos a base de polisacáridos solubles en agua que comprenden como fuente de canabinoides un aceite o extracto estandarizado de cáñamo (Cannabis sativa L.) esencialmente desprovisto de sustancias psicotrópicas.Veterinary compositions or dietary or food supplements are useful in the prevention or treatment of behavioral disorders, which are related respectively to age, problems and pain in mammals. They are also to support or strengthen the immune system, the behavioral balance of mammals, and to support the natural inflammatory response. These compositions or supplements are in the form of granules based on water-soluble polysaccharides that comprise as a source of cannabinoids a standardized oil or extract of hemp (Cannabis sativa L.) essentially devoid of psychotropic substances.

MX2019015673A 2017-06-30 2018-06-25 COMPOSITION OF VETERINARY GRANULES CONTAINING CA? AMO EXTRACT. MX2019015673A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762527463P 2017-06-30 2017-06-30
PCT/IB2018/000707 WO2019002933A1 (en) 2017-06-30 2018-06-25 Veterinary granules composition containing hemp extract

Publications (1)

Publication Number Publication Date
MX2019015673A true MX2019015673A (en) 2020-02-26

Family

ID=63042061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019015673A MX2019015673A (en) 2017-06-30 2018-06-25 COMPOSITION OF VETERINARY GRANULES CONTAINING CA? AMO EXTRACT.

Country Status (5)

Country Link
EP (1) EP3645119A1 (en)
BR (1) BR112019026635A2 (en)
CO (1) CO2020000111A2 (en)
MX (1) MX2019015673A (en)
WO (1) WO2019002933A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3106476A1 (en) * 2018-07-10 2020-01-16 Cardinal Advisory Limited Formulation of cannabinoid compounds
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. Synthesis of cannabigerol
CN111978417B (en) * 2019-09-06 2021-08-06 云南汉盟制药有限公司 Extraction method of hemp polysaccharide, product and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007046086A1 (en) * 2007-09-26 2009-04-09 Heinz Prof. Dr. Letzel Plant extract from THC-poor cannabis for the treatment of diseases
EA201791299A1 (en) * 2014-12-12 2017-12-29 ОХАЙ ЭНЕРДЖЕТИКС ПиБиСи MICROINCAPSULATED COMPOSITIONS OF CANNABINOIDS

Also Published As

Publication number Publication date
WO2019002933A1 (en) 2019-01-03
BR112019026635A2 (en) 2020-06-30
EP3645119A1 (en) 2020-05-06
CO2020000111A2 (en) 2020-01-17

Similar Documents

Publication Publication Date Title
CO2020000111A2 (en) Composition of veterinary granules containing hemp extract
CL2020000632A1 (en) Composition and method for the treatment of autism.
CO2019001043A2 (en) Cannabis composition
CL2020003368A1 (en) Composition and method of treating pain
CL2018000829A1 (en) Human anti-cd19 antibodies with high affinity
HK1252151A1 (en) Cannabis plants having modified expression of thca synthase
MX378687B (en) FAT-SOLUBLE VITAMIN FORMULATION.
BR112019007798A2 (en) oral release vehicle
BR112017025339A2 (en) nutritional compositions containing a high level of inositol and uses thereof
CL2020003373A1 (en) Composition and method of opiate sparing
CO2019000787A2 (en) New formulations and compositions of cannabis in tablets and methods for its elaboration
MX2021015256A (en) MIXTURE OF PLANT EXTRACTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL DISEASES.
CO2019007902A1 (en) Systems and methods to improve trichome formation and density in cannabis
MX2015011255A (en) Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action.
CO2021002085A2 (en) Curcuminoid compositions
BR112015020365A2 (en) bioactive fraction derived from fruit, composition, and method for isolating a bioactive fraction
CL2020003374A1 (en) Composition and method of cannabinoids to treat tept and / or anxiety
KR102403795B9 (en) Anti-allergic or antioxidant composition containing hemp seed extract
CL2017002967A1 (en) Beta-caseins a2 and antioxidant capacity.
EA201991659A1 (en) Cough Composition
MA40645A (en) INULIN-BASED PREBIOTIC PREPARATION
MX2017005700A (en) COMPOSITIONS OF GAS MICROSPHERES ENCAPSULATED IN LIPIDS AND RELATED METHODS.
MY162437A (en) Solid composition
MX2019006547A (en) Powder solid compositions, process for their preparation, formulations and use thereof.
EA201890479A1 (en) HYDROPHOBIC GEL BASED ON VITAMIN E WITHOUT SILICONE PRODUCTS FOR LOCAL APPLICATION